The use of stimulus-biased assay systems to detect agonist-specific receptor active states: Implications for the trafficking of receptor stimulus by agonists

Molecular Pharmacology

Volumn 58, Issue 6, 2000, Pages 1230-1238

  Watson, Chris ^a   Chen, Grace ^a   Irving, Paul ^a   Way, James ^a   Chen, Wen Ji ^a   Kenakin, Terry ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; CELL INTERACTION; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; ENZYME ACTIVE SITE; GENETIC TRANSFECTION; MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY; SHORT SURVEY; STIMULUS RESPONSE;

EID: 0033663775     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.6.1230     Document Type: Short Survey

References (34)

1. Effect pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus
2. Differential opioid agonist regulation of the mouse μ opioid receptor
3. Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: Evidence for agonist-specific trafficking of intracellular responses
4. Expression cloning and receptor pharmacology of human calcitonin receptors from MCF-7 cells and their relationship to amylin receptors
5. Inverse agonist activity of β-adrenergic antagonists
6. Agonist selective regulation of G proteins by cannabinoid CB1 and CB2 receptors
7. Signal transduction by calcitonin: Multiple ligands, receptors, and signaling pathways
8. Amino acids 356-372 constitute a Gi-activator sequence of the α2-adrenergic receptor and have a Phe substitute in the G-protein-activator sequence motif
9. Molecular cloning and expression a cDNA encoding the secretin receptor
10. Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium
11. Morphine activates opioid receptors without causing their rapid internalization
12. The classification of seven transmembrane receptors in recombinant expression systems
13. Agonist selective receptor active states: The next level of selectivity?
14. Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry
15. Protean agonists: Keys to receptor active states?
16. The stability of the agonist β2-adrenergic receptor-Gs complex: Evidence for agonist-specific states
17. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
18. Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein
19. Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems
20. Deduced primary structure of the alpha-subunit of the GTP-binding stimulatory protein of adenylate cyclase
21. A mutation-induced activated state of the β2-adrenergic receptor: Extending the ternary complex model
22. Effects of guanine, inosine, and xanthine nucleotides β2-adrenergic receptor/Gs interactions: Evidence for multiple receptor conformations
23. Statistical Methods. 6th ed
24. Differential signal transduction by five splice variants of the PACAP receptor
25. G-protein diversity: A distinct class of alpha subunits is present in vertebrates and invertebrates
26. Selection of distinct conformational states of the 5-HT3 receptor by full and partial agonists
27. Giactivator region of α2A-adrenergic receptors: Distinct basic residues mediate Gi versus Gs activation
28. The cubic ternary complex receptor-occupancy model. I. Model description
29. The cubic ternary complex receptor-occupancy model. II. Understanding apparent affinity
30. The cubic ternary complex receptor-occupancy model. III. Resurrecting efficacy
31. Contribution of serine residues to constitutive and agonist-induced signaling via the D2s dopamine receptor: Evidence for multiple, agonist-specific active conformations
32. μ Opioid receptor phosphorylation, desensitization and ligand efficacy